ADC Therapeutics S.A.
← Back to ADCT Overview

ADC Therapeutics S.A. (ADCT)

Profitability & Net Margin History

Current Net Margin

-27.80%

ADC Therapeutics S.A. currently has a net profit margin of -27.80%.

Financial Fundamentals

ADCTQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.02-0.01-27.80%22159
2025-09-300.02-0.04-249.38%5130
2025-06-300.02-0.06-300.68%13309
2025-03-310.02-0.04-167.59%1411
2024-12-310.02-0.03-181.71%5642
2024-09-300.02-0.04-238.13%2823
2024-06-300.02-0.04-209.90%4826
2024-03-310.02-0.05-258.16%24828
2023-12-310.02-0.09-506.44%17658
2023-09-300.01-0.05-329.86%7616
2023-06-300.02-0.05-253.71%5892
2023-03-310.02-0.06-312.63%27802
2022-12-310.07-0.02-34.61%3170
2022-09-300.08-0.05-66.31%30599
2022-06-300.02-0.06-372.30%33647
2022-03-310.05-0.02-35.83%16629
2021-12-310.02-0.03-202.12%34210
2021-09-300.01-0.07-544.22%138580
2021-06-300.00-0.07-1930.03%
2021-03-310.00-0.05
2020-12-310.00-0.06
2020-09-300.00-0.02
2020-06-300.00-0.13
2020-03-310.00-0.04
2019-12-310.00-0.04
2019-09-300.00-0.03
2019-06-300.00-0.02-1190.01%94067
2019-03-310.00-0.02-2130.68%976602
2018-12-310.00-0.03-11896.70%0
2018-09-300.00-0.03-11896.70%200422
2018-06-300.00-0.03-9892.48%0
2018-03-310.00-0.03-9892.48%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.